Human Reproductive Technologies Market Infertility Drugs and Procedures Contraceptives Drugs and Devices Global Industry Analysis Size Procedures Share Growth Trends and Forecast 2013 2019

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Autoimmune Drug Focus NOVEMBER 2014

Autoimmune Drug Focus NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 20 pages

Industry Trend Analysis - BMS Interest Underlines Vitality Of Underserved IPF Market Industry Brief - Novo Nordisk Invests In New Danish Laboratory Facility Industry Brief - BI/Lilly Revise Operational Structure Of Diabetes Alliance Industry Brief - Paediatric Type I Diabetes Diamyd/GABA Combination ...

Industries: Drug and Medication | Countries: Europe, Canada, World, United Kingdom, Sweden, Germany, Denmark, Japan, United States

World Generic Markets 24 NOVEMBER 2014

World Generic Markets 24 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 16 pages

Industry Trend Analysis - Acquisition Of Allergan Will Transform Actavis Industry Brief - Teva Launches Celecoxib In Canada Industry Brief - Beximco Gains Canadian GMP Approval Industry Brief - FDA Rescinds Ranbaxy Exclusivities Creating Opportunity For Dr Reddy's And Endo Industry Brief - Sucampo Files ...

Industries: Drug and Medication | Countries: World, Canada, United States, United Kingdom, Switzerland, Europe, Saudi Arabia, North America

RPG Life Sciences Limited (Symbol:RPGLIFE) SWOT Analysis, Strategy, Revenues and Profits

RPG Life Sciences Limited (Symbol:RPGLIFE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. RPG Life Sciences Limited SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: India, World

Mylan Laboratories Limited - Strategic SWOT Analysis Review

Mylan Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Mylan Laboratories Limited (Mylan Laboratories) is a pharmaceutical company. The company's product segments include manufacturing and supply of active pharmaceutical ingredients (APIs). The company offers its products in various therapeutic categories, including central nervous system (CNS) agents, ...

Industries: Drug and Medication | Countries: India, United States, World, Australia, South Africa, China

Parabolic Drugs Limited (PARABDRUGS) - Financial and Strategic SWOT Analysis Review

Parabolic Drugs Limited (PARABDRUGS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Parabolic Drugs Limited (PDL) is a pharmaceutical intermediate company. The company focuses on development and manufacturing of APIs (Active Pharmaceutical Ingredients) and API intermediates. It offers custom research and manufacturing services (CRAMS) to synthetic & medicinal chemistry, process ...

Industries: Drug and Medication | Countries: World

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Financial and Strategic SWOT Analysis Review

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Jagsonpal Pharmaceuticals Limited (Jagsonpal) is a pharmaceutical company. The company develops, manufactures and markets bulk drugs and pharmaceutical formulations. Jagsonpal's products include allylestrenol, dextropropoxyphene HCL, dextropropoxyphene napsylate, disulfiram, thiopental sodium, ...

Industries: Drug and Medication | Countries: Argentina, Switzerland, Sri Lanka, World

Moderate Pain - Pipeline Review, H2 2014

Moderate Pain - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 87 pages

Moderate Pain - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Moderate Pain - Pipeline Review, H2 2014', provides an overview of the Moderate Pain's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Moderate Pain, complete with comparative ...

Industries: Drug and Medication | Countries: World

Contraception - Pipeline Review, H2 2014

Contraception - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 99 pages

Contraception - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Contraception - Pipeline Review, H2 2014', provides an overview of the Contraception's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Contraception, complete with comparative ...

Industries: Drug and Medication | Countries: World

Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) - Pipeline Review, H2 2014

Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 49 pages

Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) - Pipeline Review, H2 2014', provides an overview of the Vancomycin Resistant Staphylococcus Aureus Infection (VRSA)'s ...

Industries: Drug and Medication | Countries: World

Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2014

Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 68 pages

Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2014', provides an overview of the Haemophilus Influenzae Type b Infections's therapeutic pipeline. This report provides comprehensive ...

Industries: Drug and Medication | Countries: World, India

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.